Relative bioactivities of cholecystokinins-8 and -33 on rat pancreatic acini
- PMID: 2432584
- DOI: 10.1016/0196-9781(86)90085-9
Relative bioactivities of cholecystokinins-8 and -33 on rat pancreatic acini
Abstract
The relative potencies of cholecystokinin (CCK-33) and its carboxyl terminal octapeptide (CCK-8) for stimulation of amylase release from rat pancreatic acini was measured. Porcine CCK-33 and synthetic CCK-8 were initially subjected to high pressure liquid chromatography to assess purity. Concentrations of each peptide were determined by amino acid analysis. The relative immunoreactivities of CCK-33 and CCK-8 were compared using an antibody that recognizes the common carboxyl terminus of these forms. This antibody bound CCK-8 and CCK-33 with nearly equal affinity. The relative potencies of CCK-33 and CCK-8 were then measured by comparing their abilities to stimulate amylase release from isolated rat pancreatic acini. Statistical analysis of the relative potencies of the two hormones indicated that CCK-8 was 36% more potent than CCK-33 in this assay system. These data suggest that differences in biological activities between large and small forms of CCK are not as great as previously reported.
Similar articles
-
Bioactivity of synthetic human cholecystokinin (CCK)-33 in vitro and in vivo.Gastroenterol Jpn. 1991 Feb;26(1):51-5. doi: 10.1007/BF02779509. Gastroenterol Jpn. 1991. PMID: 1706670
-
Effects of C-terminal fragments of cholecystokinin on exocrine and endocrine secretion from isolated perfused rat pancreas.Endocrinology. 1983 Dec;113(6):2210-15. doi: 10.1210/endo-113-6-2210. Endocrinology. 1983. PMID: 6196184
-
Isolation and characterization of biologically active and inactive cholecystokinin-octapeptides from human brain.Peptides. 1984 Sep-Oct;5(5):959-66. doi: 10.1016/0196-9781(84)90123-2. Peptides. 1984. PMID: 6209688
-
Bioassay of plasma cholecystokinin in rat and human: inhibition of protein synthesis prevents the decrease in the sensitivity and responsiveness of isolated rat pancreatic acini to CCK-8.Pancreas. 1989;4(4):447-51. Pancreas. 1989. PMID: 2474813
-
Natural and synthetic CCK-58. Novel reagents for studying cholecystokinin physiology.Ann N Y Acad Sci. 1994 Mar 23;713:11-21. doi: 10.1111/j.1749-6632.1994.tb44047.x. Ann N Y Acad Sci. 1994. PMID: 7514372 Review.
Cited by
-
Total synthesis, purification, and characterization of human [Phe(p-CH2SO 3Na)52, Nle32,53,56, Nal55]-CCK20-58, [Tyr52, Nle32,53,56, Nal55]-CCK-58, and [Phe(p-CH2SO3Na)52, Nle32,53,56, Nal55]-CCK-58.J Protein Chem. 1993 Oct;12(5):533-44. doi: 10.1007/BF01025118. J Protein Chem. 1993. PMID: 7511387
-
Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans.J Clin Invest. 1988 Jun;81(6):1675-81. doi: 10.1172/JCI113505. J Clin Invest. 1988. PMID: 3290250 Free PMC article.
-
Bioactivity of synthetic human cholecystokinin (CCK)-33 in vitro and in vivo.Gastroenterol Jpn. 1991 Feb;26(1):51-5. doi: 10.1007/BF02779509. Gastroenterol Jpn. 1991. PMID: 1706670
-
Interaction between gastric and upper small intestinal hormones in the regulation of hunger and satiety: ghrelin and cholecystokinin take the central stage.Curr Protein Pept Sci. 2011 Jun;12(4):293-304. doi: 10.2174/138920311795906673. Curr Protein Pept Sci. 2011. PMID: 21428875 Free PMC article. Review.
-
Enteroendocrine cells regulate intestinal homeostasis and epithelial function.Mol Cell Endocrinol. 2024 Nov 1;593:112339. doi: 10.1016/j.mce.2024.112339. Epub 2024 Aug 5. Mol Cell Endocrinol. 2024. PMID: 39111616 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
